MAPT and Alzheimer disease: The loss of tau function is coupled with increased aggregation properties (Avila et al., 2004; DeTure and Dickson, 2019) and abnormal tau is linked to the spreading of tau pathology throughout the brain in AD (DeTure and Dickson, 2019).